Oral Hypoglycaemic Agents (OHA): MOA and Drugs.pptx
910 views
23 slides
Nov 19, 2022
Slide 1 of 23
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
About This Presentation
This is a compact slide on Oral Hypoglycaemic Agents (drugs acting against diabetes, both type 1 and type 2) including its mechanism of action and drug examples.
Size: 3.32 MB
Language: en
Added: Nov 19, 2022
Slides: 23 pages
Slide Content
Oral Hypoglycaemic Agents: MOA & Drugs Anirban Kumar Bora 17.11.2022 Assistant Professor Gitanjali College of Pharmacy Lohapur, Birbhum, West Bengal.
C ontents Sulphonylureas 01 Biguanides 02 Glinides 03 4 Thiazolidinediones Gliptins 5 6 α- Glucosidase Inhibitors Glucose Transport Inhibitors 7
1 Binds to specific receptors on β- cells of islets of Langerhans Mechanism of Action Stimulation of insulin release from β-cells of pancreas 2 Blocks ATP sensitive K + Channels 3 Depolarisation and influx of Ca 2+ ions into β-cells 4 Degranulation and exocytosis of stored insulin from β- cells
2 Biguanides
1 Directly or indirectly ↓ hepatic glucose production by inhibiting the mitochondrial respiratory chain complex I Drugs 2 ↑ in AMP which in turn activates AMP activated protein kinase (AMPK) 3 Triggers release of GLP-I 4 Stimulates gut- brain- liver vagal network (that regulates hepatic glucose production) Mechanism of Action Metformin
Ancillary Mechanism of Action ↑ G lucose uptake and utilisation in skeletal muscle ↓ C arbohydrate absorption from intestine ↓ C irculating low- density (LDL) and very low density lipoproteins (VLDL)
03 Gli nides
Repaglinide Nateglinide Stimulation of insulin release from β-cells of pancreas [Insulin secretagogue] Drugs Type of Mechanism
1 Binds to specific receptors on β- cells of islets of Langerhans Mechanism of Action 2 Closure of ATP sensitive K + Channels (known as SUR1 channel) 3 Depolarisation and influx of Ca 2+ ions into β-cells 4 Degranulation and exocytosis of stored insulin from β- cells Note Administered shortly before a meal to reduce postprandial rise in blood glucose in type 2 diabetes patients
04 Thiazolidinediones
Selective agonist for peroxisome proliferator- activated receptor γ (PPAR γ ) [a nuclear hormone receptor] Regulates transcription of several insulin responsive genes ↑ Sensitivity of insulin in peripheral tissue (including adipose tissue, liver, skeletal muscle) Drugs Pioglitazone Mechanism of Action
Inhibits enzyme DPP-4 (dipeptidyl peptidase 4) Stimulates insulin secretion Prevents inactivation of incretin hormones such as GLP-1 Mechanism of Action
06 α- Glucosidase Inhibitors
Acarbose Miglitol Drugs Voglibose
Reversibly inhibit α- glucosidase enzyme [ α- glucosidase enzymes break down carbohydrates into glucose and other simple sugars that can be absorbed] Delays digestion of carbohydrates, resulting in lower postprandial glucose Mechanism of Action
07 Glucose Transport Inhibitors
Canagliflozin Dapagliflozin Drugs Empagliflozin
Inhibits sodium- glucose cotransporter 2 (SGLT2) [SGLT2 is responsible for reabsorbing filtered glucose in the tubular lumen of the kidney] Promoting glucose excretion into the urine, thereby reducing the concentration of circulating glucose Mechanism of Action